SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-053388
Filing Date
2020-04-29
Accepted
2020-04-29 16:16:59
Documents
55
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q inva-20200331x10q.htm   iXBRL 10-Q 1089339
2 EX-31.1 inva-20200331xex31d1.htm EX-31.1 13204
3 EX-31.2 inva-20200331xex31d2.htm EX-31.2 13190
4 EX-32 inva-20200331xex32.htm EX-32 15601
  Complete submission text file 0001104659-20-053388.txt   4880012

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA inva-20200331.xsd EX-101.SCH 33297
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE inva-20200331_cal.xml EX-101.CAL 60943
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE inva-20200331_def.xml EX-101.DEF 124098
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE inva-20200331_lab.xml EX-101.LAB 344478
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inva-20200331_pre.xml EX-101.PRE 255487
44 EXTRACTED XBRL INSTANCE DOCUMENT inva-20200331x10q_htm.xml XML 900733
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30319 | Film No.: 20830555
SIC: 2834 Pharmaceutical Preparations